Navigation Links
Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones
Date:5/16/2011

rogram*.  The key ingredient of Alena is a custom-formulated white bean extract (Phase 2®), which represents the first carbohydrate blocker shown in multiple studies to slow or delay the digestion and absorption of carbohydrates and to help control blood glucose after eating certain starch-laden foods*.  MedPodium's Alena™ has also been formulated to include ChromeMate® brand chromium polynicotinate that helps to metabolize fat, turn protein into muscle and convert sugar into energy.  Researchers have shown that ChromeMate's oxygen-coordinated niacin-bound chromium complex provides a safe and effective form of chromium available in a dietary supplement.*

Alena is formulated using a highly concentrated Phase 2® extract that is approximately four times more potent than other generally available Phase 2® products and was specifically manufactured for Cardium for use in MedPodium's easy-to-swallow pharmaceutical grade capsules.  Alena temporarily inhibits the alpha-amylase enzyme from digesting complex carbohydrates commonly found in modern diets, thus slowing their absorption and reducing their caloric impact.  Alena works selectively on the types of carbohydrates found in starchy foods, and does not block the absorption of "good" simple carbohydrates such as those derived from vegetables and whole grains*.  A complete dossier of Phase 2® clinical studies can be accessed at http://www.phase2info.com/pdf/phase2-product-overview.pdf.  

MedPodium Brand PlatformCardium plans to identify and evaluate additional key ingredients and formulations from around the world for use in its MedPodium healthy lifestyle brand platform, and is currently developing a selection of science-based, easy-to-use lifestyle nutraceutical supplements called Nutra-Apps™, which are expected to be marketed to the tech-focused millennial gene
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
7. Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
8. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development
11. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... --  DocResponse was ranked the most accurate ... peer-reviewed study , "Evaluation of symptom checkers for ... the July issue of The British Medical Journal ... researchers determined that performance of online symptom checkers ... first in standardized patient evaluations more often than ...
(Date:7/27/2015)... , July 27, 2015 VolitionRx ... focused on developing blood-based diagnostic tests for a broad ... that it has engaged the services of a specialty ... (GSS), to support initial U.S. market entry of its ... Under the agreement, GSS will target and select U.S. ...
(Date:7/27/2015)... , July 27, 2015 Research and ... the "Intraoperative Imaging Market by Type (Intraoperative CT, ... Europe, Asia-Pacific, ROW) - Global Forecast to 2019" ... is expected to reach a value of $2.1 Billion ... CAGR of 3.5% during the forecast period. ...
Breaking Medicine Technology:Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2
... 30 Siemens Hearing Instruments, Inc., (www.usa.siemens.com/hearing) one of ... today announced several new product models and enhancements at ... of Audiology,s (ADA) 2009 Convention held October 29-31, 2009, ... the Motion, Explorer and Nitro lines support Siemens commitment ...
... Coulter, Inc. (NYSE: BEC ), a leading developer, ... innovate complex biomedical testing, announced today third quarter and ... third quarter revenue, including $65.1 million from the recent ... year quarter, or 11.6% in constant currency. On ...
Cached Medicine Technology:Siemens Unveils New Hearing Loss Options at SPLASH: ADA's 2009 Convention 2Siemens Unveils New Hearing Loss Options at SPLASH: ADA's 2009 Convention 3Siemens Unveils New Hearing Loss Options at SPLASH: ADA's 2009 Convention 4Beckman Coulter Announces Third Quarter 2009 Results 2Beckman Coulter Announces Third Quarter 2009 Results 3Beckman Coulter Announces Third Quarter 2009 Results 4Beckman Coulter Announces Third Quarter 2009 Results 5Beckman Coulter Announces Third Quarter 2009 Results 6Beckman Coulter Announces Third Quarter 2009 Results 7Beckman Coulter Announces Third Quarter 2009 Results 8Beckman Coulter Announces Third Quarter 2009 Results 9Beckman Coulter Announces Third Quarter 2009 Results 10Beckman Coulter Announces Third Quarter 2009 Results 11Beckman Coulter Announces Third Quarter 2009 Results 12Beckman Coulter Announces Third Quarter 2009 Results 13Beckman Coulter Announces Third Quarter 2009 Results 14Beckman Coulter Announces Third Quarter 2009 Results 15Beckman Coulter Announces Third Quarter 2009 Results 16Beckman Coulter Announces Third Quarter 2009 Results 17Beckman Coulter Announces Third Quarter 2009 Results 18Beckman Coulter Announces Third Quarter 2009 Results 19Beckman Coulter Announces Third Quarter 2009 Results 20Beckman Coulter Announces Third Quarter 2009 Results 21Beckman Coulter Announces Third Quarter 2009 Results 22Beckman Coulter Announces Third Quarter 2009 Results 23Beckman Coulter Announces Third Quarter 2009 Results 24Beckman Coulter Announces Third Quarter 2009 Results 25Beckman Coulter Announces Third Quarter 2009 Results 26Beckman Coulter Announces Third Quarter 2009 Results 27Beckman Coulter Announces Third Quarter 2009 Results 28Beckman Coulter Announces Third Quarter 2009 Results 29Beckman Coulter Announces Third Quarter 2009 Results 30Beckman Coulter Announces Third Quarter 2009 Results 31Beckman Coulter Announces Third Quarter 2009 Results 32Beckman Coulter Announces Third Quarter 2009 Results 33
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... Eugene Batelli, ... an accomplished athlete. “The patient is high-end athlete, whose accomplishments include running in ... months of Achilles tendon pain, which was diagnosed as tendinitis. I did an ...
(Date:7/27/2015)... ... 27, 2015 , ... The Maricopa Community Colleges today announced a ... system to get into and complete college. , The “Bridging Success Initiative,” funded ... today with partners from across the valley. , The initiative advisory board has representatives ...
(Date:7/27/2015)... ... July 27, 2015 , ... David Gilmour ... will be performing for one additional night at each of his original four tour ... for added savings. , David Gilmour’s 2016 North America tour dates: , Thursday, March ...
(Date:7/27/2015)... (PRWEB) , ... July 27, ... ... on Global Calcium Propionate industry is a professional and in-depth research report. ... overview, industry chain structure, international market analysis etc. This report covers the ...
(Date:7/27/2015)... Chico, CA (PRWEB) , ... July 27, 2015 , ... ... has teamed up with PursuitSAFETY to support its mission of reducing the number of ... funds to help support victims and their families. PursuitSAFETY works with the police ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 3Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 3Health News:Cheap David Gilmour Tickets at Madison Square Garden (MSG), Air Canada Center, United Center and Hollywood Bowl: Additional Dates for David Gilmour Go On Sale Today 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3
... Phase II for melanoma, to begin Phase II for breast ... cancer ... today at 9:00 a.m. EDT -, BRANFORD, Conn., April 22 CuraGen Corporation,(Nasdaq: ... the quarter ended March 31, 2008, CuraGen reported a net loss,of $6.8 million, or ...
... China, April 22 /Xinhua-PRNewswire Simcere Pharmaceutical,Group (NYSE: ... of,branded generic pharmaceuticals and manufacturer of the ... announced that it has,signed a definitive agreement ... Wuhu,Zhong Ren Pharmaceutical Co. Ltd. for a ...
... for the Service,Employees International Union claimed in an ... other acts of intimidation against,officers, directors and staff ... nothing more than "free speech.", A temporary ... Court Commission Jon Rantzman remains in effect today. ...
... treatment with drug 5-fluorouracil, study says , , MONDAY, April ... used chemotherapy drug causes memory problems and other cognitive ... brain," a new study found. , Up to 50 ... problems a year after chemotherapy treatment ended, according to ...
... DANVILLE, PA. Hearing repeated stories of suffering from ... workers, a new Geisinger-led study suggests. , In a ... Social Work Practice, Geisinger Senior Investigator Joseph Boscarino, PhD, ... and secondary trauma among 236 New York City social ...
... Appointed to Board ... of Directors, CINCINNATI, April 21, 2008 ... (Jack) F. Smith (70),will retire from the board following P&G,s April board meeting ... to:, http://www.prnewswire.com/mnr/pg/32757/ Mr. Smith has served on the board since 1995 ...
Cached Medicine News:Health News:CuraGen Reports First Quarter 2008 Financial Results 2Health News:CuraGen Reports First Quarter 2008 Financial Results 3Health News:CuraGen Reports First Quarter 2008 Financial Results 4Health News:CuraGen Reports First Quarter 2008 Financial Results 5Health News:CuraGen Reports First Quarter 2008 Financial Results 6Health News:Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd. 2Health News:SEIU Claims Right of 'Free Speech' to Stalk, Harass, and Threaten Registered Nurses According to the California Nurses Association 2Health News:Common Chemotherapy Drug Linked to Memory Problems 2Health News:Common Chemotherapy Drug Linked to Memory Problems 3Health News:Procter & Gamble Announces Board Changes 2
The Shandon Cryotome E Cryostat model features an automated, precise electronic specimen advance system....
The Shandon Pathcentre is a high-volume, totally enclosed tissue processor that allows complete user control and excellent continuous reagent agitation....
... Shandon Excelsior Tissue Processor is ... using traditional reagents today. It ... outstanding features to provide benefits ... increased productivity, reagent cost savings ...
The Shandon Grosslab Grossing Workstation comes in a bench top or stand alone design for the gross examination and sectioning of specimens....
Medicine Products: